You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (2) Apply Biologicals filter
- Remove Blood and blood components filter Blood and blood components (0)
- Remove Complementary medicines filter Complementary medicines (7)
- Fees/Payments (1) Apply Fees/Payments filter
- Import/Export (1) Apply Import/Export filter
- Remove Labelling/Packaging filter Labelling/Packaging (1)
- Legislation (3) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (1) Apply Manufacturing filter
- Remove Medical devices/IVDs filter Medical devices/IVDs (55)
- Medical devices safety (1) Apply Medical devices safety filter
- Remove Medicinal cannabis filter Medicinal cannabis (1)
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- Remove OTC medicines filter OTC medicines (12)
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Remove Prescription medicines filter Prescription medicines (7)
- Scheduling (56) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (3) Apply Therapeutic goods regulation filter
- (-) Remove Medicinal cannabis filter Medicinal cannabis
- (-) Remove Complementary medicines filter Complementary medicines
- (-) Remove OTC medicines filter OTC medicines
- (-) Remove Blood and blood components filter Blood and blood components
- (-) Remove Medical devices/IVDs filter Medical devices/IVDs
- (-) Remove Labelling/Packaging filter Labelling/Packaging
- (-) Remove Prescription medicines filter Prescription medicines
Software as a Medical Device (IMDRF Working Group)
Closed on 27 May 2015
Proposed performance requirements and risk mitigation strategies for HIV tests
Closed on 30 January 2015
Software as a medical device (IMDRF working group)
Closed on 31 May 2014
Supply of in vitro diagnostic devices for self-testing (home testing) for the presence of human immunodeficiency virus in Australia
Closed on 6 May 2014
Proposed amendments to the new regulatory framework for In Vitro Diagnostic medical devices (IVDs)
Closed on 7 June 2013
Regulation Impact Statement: Changes to premarket assessment requirements for medical devices
Closed on 3 June 2013
Loratadine and desloratadine: proposed advisory statements for medicines
Closed on 7 December 2012
Fexofenadine and loperamide: proposed advisory statements for medicines
Closed on 4 June 2012
Reforms in the medical devices regulatory framework
Closed on 17 December 2010
Draft guidance on the regulation of custom made medical devices
Closed on 31 March 2009